"The pill" suppresses adolescent bone growth, no matter the estrogen dose
Brajic et al examine the benefits and risks of adolescent use of continuous or cyclic combined hormonal contraceptives (CHC). Long-acting reversible contraceptive agents, such as implants and intrauterine devices, are ideally first-line methods for adolescents because of improved adherence and bone...
Gespeichert in:
| Veröffentlicht in: | Canadian Medical Association journal (CMAJ) 2021-12, Vol.193 (50), p.E1922-E1922 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | E1922 |
|---|---|
| container_issue | 50 |
| container_start_page | E1922 |
| container_title | Canadian Medical Association journal (CMAJ) |
| container_volume | 193 |
| creator | Brajic, Tatjana S Goshtasebi, Azita Goldberg, Tamara B L Berenson, Abbey B Prior, Jerilynn C |
| description | Brajic et al examine the benefits and risks of adolescent use of continuous or cyclic combined hormonal contraceptives (CHC). Long-acting reversible contraceptive agents, such as implants and intrauterine devices, are ideally first-line methods for adolescents because of improved adherence and bone safety. However, a prospective, population-based, 2-year observational study of Canadian adolescents aged 16-19 years showed that those who used CHC had decreased gains in femoral bone mineral density compared with those who did not use CHC. Loss of bone mineral density on CHC was unrelated to dose of ethinyl estradiol. Earlier data had already shown the lack of a dose effect from CHC estrogen on bone; patients on 20-35 μg ethinyl estradiol CHC formulations all had suppressed markers of bone remodelling. Recent meta-analysis comparing adolescents who did and did not use CHC also showed impaired accrual of bone mineral density among CHC users across a wide range of doses. |
| doi_str_mv | 10.1503/cmaj.80396 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8687508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A687003768</galeid><sourcerecordid>A687003768</sourcerecordid><originalsourceid>FETCH-LOGICAL-c596t-f6358dfc2d4c5064c657675ac1aba94ffe45733bb47ed10e9b0663831ea6b9a33</originalsourceid><addsrcrecordid>eNqVkluL1DAYhoMo7rh64w-QMoKo2DFp2rS5EZbFw8CioOt1SNOvnQxp001SD__e1F3XqcyNyUUgefJ-pxehxwRvSIHpa9XL_abClLM7aEXyqkozmvG7aIWrDKeU5-wEPfB-j-OiWXkfndCcU1wyvkLb9eUOklEbs078NI4OvAefyMYa8AqGkNR2gKRz9nvYvUoGm_QyBHBJiN_AB2c7GJLGeniI7rXSeHh0c56ir-_eXp5_SC8-vd-en12kquAspC2jRdW0KmtyVWCWK1aUrCykIrKWPG9byIuS0rrOS2gIBl5jxmhFCUhWc0npKXpzrTtOdQ_NnKOTRoxO99L9FFZqsXwZ9E509puoWFUWuIoCz28EnL2aYg2i17FUY-QAdvIiYySjnBQER_TpP-jeTm6I5c1USTjnWf6X6qQBoYfWxrhqFhVnMWZsesnmsOkRKnYPYpKxx62O1wt-fYRXo74Sh9DmCBR3A71WR1VfLD5EJsCP0MnJe7H98vk_2I9L9tkBuwNpws5bMwVtB78EX16DylnvHbS3kyNYzHYWs53FbztH-MnhrG_RP_6lvwAnI-rY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2617199924</pqid></control><display><type>article</type><title>"The pill" suppresses adolescent bone growth, no matter the estrogen dose</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Brajic, Tatjana S ; Goshtasebi, Azita ; Goldberg, Tamara B L ; Berenson, Abbey B ; Prior, Jerilynn C</creator><creatorcontrib>Brajic, Tatjana S ; Goshtasebi, Azita ; Goldberg, Tamara B L ; Berenson, Abbey B ; Prior, Jerilynn C</creatorcontrib><description>Brajic et al examine the benefits and risks of adolescent use of continuous or cyclic combined hormonal contraceptives (CHC). Long-acting reversible contraceptive agents, such as implants and intrauterine devices, are ideally first-line methods for adolescents because of improved adherence and bone safety. However, a prospective, population-based, 2-year observational study of Canadian adolescents aged 16-19 years showed that those who used CHC had decreased gains in femoral bone mineral density compared with those who did not use CHC. Loss of bone mineral density on CHC was unrelated to dose of ethinyl estradiol. Earlier data had already shown the lack of a dose effect from CHC estrogen on bone; patients on 20-35 μg ethinyl estradiol CHC formulations all had suppressed markers of bone remodelling. Recent meta-analysis comparing adolescents who did and did not use CHC also showed impaired accrual of bone mineral density among CHC users across a wide range of doses.</description><identifier>ISSN: 0820-3946</identifier><identifier>EISSN: 1488-2329</identifier><identifier>DOI: 10.1503/cmaj.80396</identifier><identifier>PMID: 34930769</identifier><language>eng</language><publisher>Canada: CMA Joule Inc</publisher><subject>Adolescent ; Birth control ; Bone density ; Bone Development ; Estrogens ; Humans ; Letters ; Systematic review ; Teenagers</subject><ispartof>Canadian Medical Association journal (CMAJ), 2021-12, Vol.193 (50), p.E1922-E1922</ispartof><rights>COPYRIGHT 2021 CMA Joule Inc.</rights><rights>Copyright Joule Inc Dec 20, 2021</rights><rights>2021 CMA Joule Inc. or its licensors 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687508/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687508/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34930769$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brajic, Tatjana S</creatorcontrib><creatorcontrib>Goshtasebi, Azita</creatorcontrib><creatorcontrib>Goldberg, Tamara B L</creatorcontrib><creatorcontrib>Berenson, Abbey B</creatorcontrib><creatorcontrib>Prior, Jerilynn C</creatorcontrib><title>"The pill" suppresses adolescent bone growth, no matter the estrogen dose</title><title>Canadian Medical Association journal (CMAJ)</title><addtitle>CMAJ</addtitle><description>Brajic et al examine the benefits and risks of adolescent use of continuous or cyclic combined hormonal contraceptives (CHC). Long-acting reversible contraceptive agents, such as implants and intrauterine devices, are ideally first-line methods for adolescents because of improved adherence and bone safety. However, a prospective, population-based, 2-year observational study of Canadian adolescents aged 16-19 years showed that those who used CHC had decreased gains in femoral bone mineral density compared with those who did not use CHC. Loss of bone mineral density on CHC was unrelated to dose of ethinyl estradiol. Earlier data had already shown the lack of a dose effect from CHC estrogen on bone; patients on 20-35 μg ethinyl estradiol CHC formulations all had suppressed markers of bone remodelling. Recent meta-analysis comparing adolescents who did and did not use CHC also showed impaired accrual of bone mineral density among CHC users across a wide range of doses.</description><subject>Adolescent</subject><subject>Birth control</subject><subject>Bone density</subject><subject>Bone Development</subject><subject>Estrogens</subject><subject>Humans</subject><subject>Letters</subject><subject>Systematic review</subject><subject>Teenagers</subject><issn>0820-3946</issn><issn>1488-2329</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqVkluL1DAYhoMo7rh64w-QMoKo2DFp2rS5EZbFw8CioOt1SNOvnQxp001SD__e1F3XqcyNyUUgefJ-pxehxwRvSIHpa9XL_abClLM7aEXyqkozmvG7aIWrDKeU5-wEPfB-j-OiWXkfndCcU1wyvkLb9eUOklEbs078NI4OvAefyMYa8AqGkNR2gKRz9nvYvUoGm_QyBHBJiN_AB2c7GJLGeniI7rXSeHh0c56ir-_eXp5_SC8-vd-en12kquAspC2jRdW0KmtyVWCWK1aUrCykIrKWPG9byIuS0rrOS2gIBl5jxmhFCUhWc0npKXpzrTtOdQ_NnKOTRoxO99L9FFZqsXwZ9E509puoWFUWuIoCz28EnL2aYg2i17FUY-QAdvIiYySjnBQER_TpP-jeTm6I5c1USTjnWf6X6qQBoYfWxrhqFhVnMWZsesnmsOkRKnYPYpKxx62O1wt-fYRXo74Sh9DmCBR3A71WR1VfLD5EJsCP0MnJe7H98vk_2I9L9tkBuwNpws5bMwVtB78EX16DylnvHbS3kyNYzHYWs53FbztH-MnhrG_RP_6lvwAnI-rY</recordid><startdate>20211220</startdate><enddate>20211220</enddate><creator>Brajic, Tatjana S</creator><creator>Goshtasebi, Azita</creator><creator>Goldberg, Tamara B L</creator><creator>Berenson, Abbey B</creator><creator>Prior, Jerilynn C</creator><general>CMA Joule Inc</general><general>CMA Impact, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>ISR</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M3G</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211220</creationdate><title>"The pill" suppresses adolescent bone growth, no matter the estrogen dose</title><author>Brajic, Tatjana S ; Goshtasebi, Azita ; Goldberg, Tamara B L ; Berenson, Abbey B ; Prior, Jerilynn C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c596t-f6358dfc2d4c5064c657675ac1aba94ffe45733bb47ed10e9b0663831ea6b9a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>Birth control</topic><topic>Bone density</topic><topic>Bone Development</topic><topic>Estrogens</topic><topic>Humans</topic><topic>Letters</topic><topic>Systematic review</topic><topic>Teenagers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brajic, Tatjana S</creatorcontrib><creatorcontrib>Goshtasebi, Azita</creatorcontrib><creatorcontrib>Goldberg, Tamara B L</creatorcontrib><creatorcontrib>Berenson, Abbey B</creatorcontrib><creatorcontrib>Prior, Jerilynn C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business & Current Affairs Database</collection><collection>Canadian Business & Current Affairs Database (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>CBCA Reference & Current Events</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian Medical Association journal (CMAJ)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brajic, Tatjana S</au><au>Goshtasebi, Azita</au><au>Goldberg, Tamara B L</au><au>Berenson, Abbey B</au><au>Prior, Jerilynn C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>"The pill" suppresses adolescent bone growth, no matter the estrogen dose</atitle><jtitle>Canadian Medical Association journal (CMAJ)</jtitle><addtitle>CMAJ</addtitle><date>2021-12-20</date><risdate>2021</risdate><volume>193</volume><issue>50</issue><spage>E1922</spage><epage>E1922</epage><pages>E1922-E1922</pages><issn>0820-3946</issn><eissn>1488-2329</eissn><abstract>Brajic et al examine the benefits and risks of adolescent use of continuous or cyclic combined hormonal contraceptives (CHC). Long-acting reversible contraceptive agents, such as implants and intrauterine devices, are ideally first-line methods for adolescents because of improved adherence and bone safety. However, a prospective, population-based, 2-year observational study of Canadian adolescents aged 16-19 years showed that those who used CHC had decreased gains in femoral bone mineral density compared with those who did not use CHC. Loss of bone mineral density on CHC was unrelated to dose of ethinyl estradiol. Earlier data had already shown the lack of a dose effect from CHC estrogen on bone; patients on 20-35 μg ethinyl estradiol CHC formulations all had suppressed markers of bone remodelling. Recent meta-analysis comparing adolescents who did and did not use CHC also showed impaired accrual of bone mineral density among CHC users across a wide range of doses.</abstract><cop>Canada</cop><pub>CMA Joule Inc</pub><pmid>34930769</pmid><doi>10.1503/cmaj.80396</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0820-3946 |
| ispartof | Canadian Medical Association journal (CMAJ), 2021-12, Vol.193 (50), p.E1922-E1922 |
| issn | 0820-3946 1488-2329 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8687508 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Adolescent Birth control Bone density Bone Development Estrogens Humans Letters Systematic review Teenagers |
| title | "The pill" suppresses adolescent bone growth, no matter the estrogen dose |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T15%3A18%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%22The%20pill%22%20suppresses%20adolescent%20bone%20growth,%20no%20matter%20the%20estrogen%20dose&rft.jtitle=Canadian%20Medical%20Association%20journal%20(CMAJ)&rft.au=Brajic,%20Tatjana%20S&rft.date=2021-12-20&rft.volume=193&rft.issue=50&rft.spage=E1922&rft.epage=E1922&rft.pages=E1922-E1922&rft.issn=0820-3946&rft.eissn=1488-2329&rft_id=info:doi/10.1503/cmaj.80396&rft_dat=%3Cgale_pubme%3EA687003768%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2617199924&rft_id=info:pmid/34930769&rft_galeid=A687003768&rfr_iscdi=true |